Cellectis S.A. Files Routine 6-K Disclosure
Ticker: CLLS · Form: 6-K · Filed: Oct 22, 2024 · CIK: 1627281
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Cellectis S.A. filed a routine 6-K, no major news here.
AI Summary
Cellectis S.A. filed a Form 6-K on October 22, 2024, to report its status as a foreign private issuer. The company, based in Paris, France, is required to file annual reports under Form 20-F. This filing does not contain specific financial updates or operational news but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating ongoing compliance with SEC reporting requirements.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 001-36891 (company) — SEC File Number
- 241384572 (company) — Film Number
- 8 RUE DE LA CROIX JARRY (company) — Business Address
- PARIS, LLE-DE-FRANCE (company) — City, State
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the exact name of the registrant?
The exact name of the registrant is Cellectis S.A.
Where is Cellectis S.A. located?
Cellectis S.A. is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Does Cellectis S.A. file annual reports under Form 20-F?
Yes, Cellectis S.A. indicates by check mark that it files annual reports under cover of Form 20-F.
What is the filing date of this report?
The date of the report is October 22, 2024.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2024-10-22 06:07:27
Filing Documents
- f6k_102224.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-24-005728.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: October 22, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer